PAR - Ready to Break All Time High
The chart of PAR Drugs shows a strong accumulation phase followed by consistent base shifts, indicating a steady uptrend with strong support levels forming at higher price ranges.
Key observations:
Strong Base Formation: The stock established a solid support level early on, acting as the foundation for the uptrend.
Base Shifts:
Multiple higher bases were formed, showing sustained buying interest and bullish momentum.
10-Week EMA Support:
The stock repeatedly tested and respected the 10-week EMA, confirming it as a dynamic support level.
Bullish Candle with Volume:
The latest bullish candle is supported by high volume, signaling strong buying interest and potential for further upside.
Huge Volume Activity:
The significant spike in volume during recent moves suggests institutional participation.
Key observations:
Strong Base Formation: The stock established a solid support level early on, acting as the foundation for the uptrend.
Base Shifts:
Multiple higher bases were formed, showing sustained buying interest and bullish momentum.
10-Week EMA Support:
The stock repeatedly tested and respected the 10-week EMA, confirming it as a dynamic support level.
Bullish Candle with Volume:
The latest bullish candle is supported by high volume, signaling strong buying interest and potential for further upside.
Huge Volume Activity:
The significant spike in volume during recent moves suggests institutional participation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.